1. Detection Technologies for Biological Toxins
2. Medical Aspects of Bioterrorism
3. Capsaicin: A Novel Antidote against Botulinum Neurotoxin A.
4. Biohazards of Botulinum Neurotoxins
5. Bioterrorism and Biological Toxins
6. The Diverse Roles of Botulinum Toxins
7. Biological Weapons and Toxins: A Short History and Look at the Future
8. Biotoxins and Bioterrorism: Ricin and Saxitoxin
9. Genotoxic Potential of Micrurus corallinus Venom on the DNA of Human Lymphocytes
10. Comet Assay and Micronucleus Tests to Assess Damage to the DNA of Human Lymphocytes Induced by the Bothrops jararaca Venom
11. Effect of Zingiber officinale Plant Extract on the Differential Control of Growth, Apoptotic Activity and Gene Expression in Human Breast Cancer Cells
12. Structural Interpretation for the Subnanomolar Affinity of Muscarinic Toxin 7 for Human Muscarinic Acetylcholine Receptor 1 by Modeling Protein-Protein Interaction
13. Crotamine Pharmacology Revisited: Novel Insights Based on the Inhibition of Kv Channels
14. Evaluation of the Cytotoxic Activity of Rhinella schneideri Toad Poison on Tumor Cells and on Healthy Mononuclear Cells
15. New Perspective for Therapy Against Seizures Using Molecules From Rhinella schneideri Toad Poison
16. Marine Pharmacology and the Late 2011 Marine Pharmaceuticals Pipeline
17. Novel Marine Compounds in Studies of Nicotinic Acetylcholine Receptors
18. Comparative Toxicity of Binase towards Tumor and Normal Cells
19. Purification and Determination of Antibacterial Constituent, L-Amino Acid Oxidase from Calloselasma rhodostoma and Ophiophagus Hannah
20. CFTR as a New Target for Crotoxin: Potential Application for Cystic Fibrosis
21. Anti-endotoxin Effects and Pharmacology of the Immune Selective Anti-Inflammatory Derivatives (ImSAIDs)
22. Engineering of an HB-EGF Inhibitor from the Diphtheria Toxin Receptor–Binding Domain for the Treatment of HB-EGF-Related Diseases
23. Transformation of the Naturally Occurring Frog Skin Peptide, Alyteserin-2a into a Potent Anti-cancer Agent
24. Recombinant Hybrid Proteins from Cobra Venom Factor and Human C3: Promising Agents for Therapeutic Intervention in Complement-Mediated Diseases
25. Viability of Fibrin Sealant from Snake Venom as Scaffold to Rat Marrow-Derived Mesenchymal Stem Cells
26. nAChR Antagonist as Chemotherapeutic Agents of Certain Lung Cancer Types Expressing Cholinergic System. A Case of Snake Three-Fingered Toxins and Alkylpyridinium Polymers from Marine Sponge
27. Development of a Virtual System to Support Clinical Toxinology Research
28. Sea Anemone Peptides Modulate TRPV1 Activity and Produce Analgesia Without Hyperthermic Effect
29. Russelobin, a Non-toxic Thrombin-like Serine Protease from the Venom of Russell's Viper ( Daboia russelli russelli ): Possible Applications in Cardiovascular Drug Development
30. Antimicrobial Peptides from Arachnid Venoms and their Biological Activity in the Presence of Commercial Antibiotics
31. Spider-venom Peptides that Target the Human NaV1.7 channel: Potential Analgesics for the Treatment of Chronic Pain
32. Development of High Throughput Calcium Channel Assays to Accelerate the Discovery of Novel Toxins Targeting Human Cav2.2 Channels
33. Mass Spectrometry as a Tool to Search Specific Ligands for G-Protein-Coupled Receptors
34. Miniaturization of μ-Conotoxins as Peptidomimetic Strategy to Develop Selective Sodium Channel Blockers
35. Development of Guanidinium-Toxin-Based Sodium Channel Blockers as PET Imaging Agents and Therapeutics for Diagnosing and Treating Pain
36. Random Peptide Library Based on a Spider Neurotoxin, and Utilization of the Library in in vitro Evolution Directed to GPCR Ligands
37. A Sea Anemone Toxin to Treat Autoimmune Diseases: ShK and its Analogs
38. Development of the Sea Anemone Toxin ShK-186 for the Treatment of Autoimmune Diseases: PK and ADME Perspectives
39. Discovery and Development of χ-Conopeptides for the Treatment of Pain
40. The Anti-cancer Activity of the Venom from Spider Macrothele raveni in vitro and in vivo
41. Anti-Inflammatory Effect of Honey Bee Venom on Wistar Rats Induced Poly Cystic Ovarian Syndrome by Estradiol Valerate
42. Effect of Conotoxins on GABAC Receptor
43. Melittin Peptide Kills Trypanosoma cruzi Epimastigotes and Trypomastigotes Forms by Different Cell Death Phenotypes
44. Leishmanicidal Effects of a Phospholipase A2 Isolated from Crotalus viridis viridis Snake Venom
45. Carbon-13 and Nitrogen-15 Turnover in Serum of Bubaline Donors of Biological Material for Medical Use
46. Biological Features of an Enantiomeric Antimicrobial Peptide from Scorpion Venom
47. Rational Development of Novel Leads from Animal Secretion Based on Coagulation and Cell Targets
48. Use of Connectivity Maps and Platform Technologies for Drug Lead/Biosimilar Discovery in Venoms
49. The Origin and Evolution of Metalloproteinases in the Venom of Snakes
50. Tetrodotoxin in North-American Newts
51. Evolution of a Neurotoxin from a Defensin
52. Divergence in the Biological Activity and Composition of Venom from Mackay (QLD) and Barossa/Adelaide (SA) Populations of Australian Pseudonaja textilis (Serpentes: Elapidae): An Important Role of Procoagulants in Rodent Prey Incapacitation
53. Evolutionary Expansion of Venom Genes in the King Cobra Genome
54. Individual Venom Profiling of Crotalus durissus terrificus Specimens from a Geographically Limited Region: Crotamine Assessment and Captivity Evaluation on the Biological Activities
55. Intraspecific Variation of Biological Activities in Venoms from Wild and Captive Bothrops jararaca
56. The Evolutionary Origins of Monotreme Crural Glands
57. Structural Characteristics and Evolution of A Novel Venom Phospholipase A2 Gene from Protobothrops flavoviridis
58. Functional Redundancy in Venoms is an Evolutionary By-Product
59. Understanding the Chemical Diversity of Spider Venoms Using a Combined Genomic, Transcriptomic and Proteomic Approach
60. Glycan Structures and Intrageneric Variations of Acidic Phospholipases A2 from Tropidolaemus Venom
61. A Phylogenetic Framework for the Study of Convergence and Divergence in Scorpion Venoms
62. Tentacles of Venom: Molecular Evolution of Coleoid Venoms
63. Discovery of the Nicotinic Receptor Toxin Anabaseine in a Polystyliferan Nemertine
64. Centipede Venoms: Old and Unusual
65. The Phylogenetic Scale of Venom Variation in Haplogyne Spiders
66. β-defensin-like genes in Brazilian Poisonous Snakes
67. Comparative Analysis of Transcriptomes of Phoneutria pertyi and P. nigriventer Venom Glands
68. Substrate range and specificity of the SicTox phospholipase D toxins
69. Recurrent, Persistent, or Late, New-Onset Hematologic Abnormalities in Crotaline Snakebite
70. Purification and Characterization of New Platelet Aggregation Inhibitor with Dissociative Effect on ADP-Induced Platelet Aggregation, from Protobothrops Venom in Japan
71. Antiplatelet Activity and Mass Spectrometric Study of Venoms from Two Iranian Vipers, Echis carinatus and Cerastes persicus fieldi
72. A Novel Family of Factor Xa Inhibitors from the Salivary Gland of Sandfly Vector of Leishmaniasis, Lutzomyia longipalpis.
73. Novel Anticoagulants from Snake Venom
74. Plant Latex Proteases: An Insight into their Procoagulant Activity
75. The P-I Metalloproteinase from Cerastes cerastes Snake Venom Inhibits Human Platelet Aggregation
76. An Antiplatelet Peptide, Lahirin, from Indian Monocled Cobra Venom
77. Anticoagulant Activity of Moon Jellyfish ( Aurelia aurita ) Tentacle Extract
78. Evaluation of the Efficacy of Treatment Using Bothropic or Bothropic/Crotalic Antivenin in Bothrops jararacussu (VIPERIDAE) Experimental Envenomation
79. Hemostatic Disturbances Evoked by Young and Adult Bothrops jararaca Snake Venoms: Analysis of the Envenoming Process and the Recovery after Specific Antivenin Treatment
80. Purification of a Prothrombin Activator from Bothrops moojeni Snake Venom
81. BaPLA2-IV, a New Type Thrombin Inhibitor, Non Cytotoxic Phospholipase A2 From Bothrops atrox Venom
82. Anticoagulant Activity of Crotalic Venoms on Whole Blood Samples from Chickens and Rats
83. Clodomiro Picado, Róger Bolaños, and the Beginnings of Toxinological Research in Central America
84. The Poisoner's Garden: Plants Used to Curse and Kill
85. TOXIN REVIEWS: The First 30 Years
86. From Medicine to Toxinology and Back to Medicine, and the Eternal Role of Snakes in Therapy
87. Antivenom Production by Instituto Butantan: 110 Years of Experience
88. Saul Wiener: From Kristallnacht to Toxinology and Fragile X.
89. Cobra Venom Factor, an Intriguing Venom Component: Over 100 Years of Research, and Counting
90. Proteomic Analysis of the Molecular Targets of a Peptide from Wasp Venom Through Developing of an Analytical Platform
91. Proteomic analyses of the Venom from the Giant Ant Dinoponera quadriceps : A Comparative Study and Characterization of the Major Components of the Venom Derived from 4 Different Areas of Brazil
92. Centipede Envenomation: 104 Cases from Bangkok, Thailand
93. Mechanisms Implicated In Cell Proliferation and Cell Survival Induced By Recombinant Losac, A Cell Adhesion Molecule From Lonomia oblique
94. Bee Venom and Pain
95. Biological and Immunochemical Characterization of Premolis semirufa Caterpillar-Bristles Toxic Components
96. Chemical and Biological Characterization of a Novel Neuropeptide in the Venom of Solitary Digger Wasp
97. Insulin-Binding Protein-Like Venom Protein of the Solitary Hunting Wasp, Eumenes pomiformis (Hymenoptera: Eumenidae)
98. Transcriptomic and Peptidomic Characterisation of the Conus marmoreus Venom: Insights on Conopeptide Diversity and Venomic Processing
99. The Venom of Conus geographus Revisited
100. The Nematocyst Venom of Hydra: What is it Composed of and How Did it Evolve?
101. Manipulation of Zoanthids in Home Marine Aquarium: Unexpected Cause of Intoxication Involving a Whole Family
102. Convergent Evolution of Sodium ion Selectivity in Metazoan Neuronal Signaling
103. Emergent Marine Toxins in Europe: New Challenges for Scientists and Regulatory Authorities
104. New Actinoporin from the Northern Pacific Sea Anemone Urticina crassicornis
105. Discovery, Characterization, and Functional Implications of Conotoxins from Cone Snails Species of the Americas
106. Molecular Diversity of Box Jellyfish Toxins
107. The Chemical Landscape of Cnidarians as Viewed Through the Lens of Pore-Forming Proteins
108. Cardiovascular and Hemolytic Effects of Sp-CTx a Cytolysin Isolated from the Scorpionfish, Scorpaena plumieri
109. A Comparison of the Structural Characteristics of the Nematocysts of the “Fire Corals” Millepora alcicornis and M. complanata , and their Hemolytic and Vasoconstrictor Effects
110. Voltage Sensor Trapping in Voltage-Gated K-Channels by the Marine Neurotoxin Gambierol
111. State of the Art of Palytoxin and Analogs Analytical Methods for Seafood Monitoring
112. Cathepsin B/X is Secreted by Echinometra lucunter Sea Urchin Spines, a Structure Rich in Granular Cells and Toxins
113. Effects of Successive Subculture and Various Culture Conditions on Growth and PSP Productivity of the Toxic Dinoflagellate Alexandrium catenella
114. Effect of Byproducts from Artemia salina Culture Medium on PSP Toxicity and Toxin Composition of Alexandrium catenella
115. Two Proteins Homologous to Pufferfish Saxitoxin- and Tetrodotoxin-Binding Protein (PSTBP) Found in the Plasma of Non-Toxic Cultured Specimens of the Pufferfish ( Takifugu rubripes)
116. Systemic Toxicity of the “Fire Coral” Millepora complanata : Isolation of a Non-Protein Vasoconstrictor Fraction with Lethal Activity in Mice
117. Identification and Characterization of α-Conotoxins in Conus purpurascens
118. Primary Structures of Proteinaceous Toxins from Three Species of Scorpaeniform Fish (Lionfish, Pterois lunulata , Scorpionfish, Inimicus japonicus and Waspfish, Hypodytes rubripinnis )
119. Characterization of Local Inflammatory Response Induced by Scorpion Fish, Scorpaena plumieri Venom in a Mouse Model of Tissue Injury
120. The Atypical Activity Profile of bru1b, an α-Conotoxin from the Venom of Conus brunneus
121. Venom Composition Changes during Prey Capture in Conus textile
122. Acute Toxicity and Brine Shrimp Cytotoxicity Induced by the Venom of the Fire Coral M. alcicornis Collected in the Mexican Caribbean
123. Effects of Cyanobacterial Bloom on Fish: Proteomics and Histological Investigation on the Medaka Oryzias Latipes
124. Biogeography of Microcystins
125. Cadherin Binding Is Not a Limiting Step for Bacillus thuringiensis subs. israelensis Cry4Ba Toxicity to Aedes aegypti Larvae
126. Magnetic Resonance Imaging and Spectroscopy Study of Microcystin LR Hepatotoxicity
127. Urease of Helicobacter pylori: Roles in Inflammation and Platelet Activation
128. Human iPS Neuronal Platform for Botulinum Neurotoxins
129. Retrograde Trafficking at the Presynaptic Nerve Terminal Using Bacterial Toxins
130. Water Bacterial Activities Involved in Immune Depression of Haemodialysis Patients
131. Unexpected Hazard Due to Fuminaisin Toxin Contaminating Herbal Teas in Saudi Arabia
132. Determination of Histamine and Histamine-forming Bacteria in Striped Marlin Fillets ( Tetrapturus audax ) Implicated in a Food-borne Poisoning
133. Root Toxicity of the Mycotoxin Botryodiplodin in Soybean Seedlings
134. Cytotoxic and Proteolytic Molecules of the Human Parasite Dientamoeba fragilis , Identified by RNA seq, Provide Support for its Pathogenic Capacity
135. Evaluation of Cardiotoxic Effects of Microcystin–LR in Mouse Isolated Hearts
136. The Allosteric Binding Site for ρ-TIA on the Extracellular Surface of the α1B- Adrenoceptor
137. Neuropathies of Spinal Cord Development of Rat Pups Maternally Fed on Fried Potato Chips
138. Nickel hepatotoxicity in rats and trials for protection using antioxidants
139. Comparison of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Blockade for the Prevention of Premalignant Changes in the Liver
140. Identification, Pharmacological and Structural characterization and Engineering of Three-finger Toxins interacting with GPCRs
141. Lipid Bilayer Condition Abnormalities Following Macrovipera lebetina obtusa and Montivipera raddei Snake Envenomation
142. From alpha-Conotoxins and alpha-Neurotoxins to Endogenous “Prototoxins" and Binding Sites in Nicotinic Acetylcholine Receptors
143. Exploring ‘Labyrinth’ of Pain with Scorpion ‘Sting’
144. Analgesic Effect of Crotalphine in a New Model of Rat Bone Cancer Pain
145. In vitro Vascular Activity of Crude Bungarus candidus and Bungarus fasciatus Crude Venoms
146. An Insecticidal Spider Toxin that Acts as a Positive Allosteric Modulator of Insect Nicotinic Acetylcholine Receptors
147. Isolation and Pharmacological Characterisation of Neurotoxins from the Venom of Three Species of Australian Copperheads ( Austrelaps spp. ) and the Efficacy of Tiger Snake Antivenom to Prevent or Reverse Neurotoxicity
148. Characterization of Inflamin from Aipysurus eydouxii : A Novel Class of Toxin that Induces Inflammation
149. The Role of the Lymphatic System in the Absorption of Micrurus fulvius Venom
150. Tailoring the Selectivity of Anuroctoxin for Kv1.3 K+ Channels
151. Immuno-Inflammatory Response after Scorpion Envenomation: Potential Role of Eïcosanoids and Histamine H1-Receptor
152. Effect of Crotoxin on Secretory Activity of Peritoneal Macrophages Co-cultivated with Tumor Cells. Involvement of Formyl Peptide Receptors
153. Biochemical and Pharmacological Characterization of Three-Finger Neurotoxins from the Venom of Eastern Coral Snake ( Micrurus fulvius fulvius )
154. First Pharmacological Study of the Venom of a Rare African Snake, Naja multifasciata duttoni
155. Expression of two endoplasmic reticulum stress markers, GRP78 and GADD153, is involved in the mechanism of action of the Amblyomin-X.
156. Neuromuscular activity of Bothrops fonsecai Snake Venom and its Neutralization by Commercial Bothropic Antivenom
157. Validation of an Analytical Method to Measure Neutralizing Potency of Anti Loxosceles Plasma
158. EqT II Causes Endothelial Cell Damage and Intracellular Ca2+ Riske in ECV-304
159. Synaptophysin Expression and Neurotoxic Effects of Some Bothropic Venoms and Toxins
160. Role of SVMPs, Matrikines and TLR4 in Snake Venom Induced Edema and Inflammation
161. Unusual Plant Poisoning from Anabasine in an Isolated Community Following Ingestion of Tree Tobacco Leaves ( Nicotiana glauca )
162. Membrane-disturbing Properties of Urease and Derived Recombinant Peptides
163. Antioxidant Effect of Camellia Sinensis (Green Tea) Extract Attenuate Acrylamide Induced Testicular Damage in Albino Rats
164. Evaluation of Anticancer Activity Promoted by Molecules Contained in the Extracts of Thevetia peruviana
165. Molecular Cloning, Expression and Structure-Function Analysis of Neopladine-2, an Antineoplastic Peptide from Tityus discrepans Scorpion Venom
166. Toxins of Tityus Serrulatus Scorpion Venom Induce Inflammatory Mediators in vitro
167. Novel Potassium Channel Blocker Venom Peptides from Mesobuthus gibbosus (Scorpiones: Buthidae)
168. Tityus serrulatus Venom Induces a Higher Lung Inflammation in Mice Selected for Maximal Inflammatory Response
169. Tityus serrulatus Scorpion Laboratory Breeding and Venom Collection for Antivenom Production and Research
170. Identification of a Dynorphin-Degrading Metallopeptidase Releasing Leu-Enkephalin in Brazilian Tityus spp. Scorpion Venoms
171. Comments on the Venom Yield of Tityus trivittatus , Considering Two Methodologies of Extraction
172. Mapping the Receptor Sites of Scorpion Toxins at Voltage-gated Sodium Channels
173. Characterisation of the Venom of an Australian Scorpion, Urodacus yaschenkoi : Proteome and Transcriptome Analysis
174. In vitro Folding of a Recombinant Beta-Scorpion Neurotoxin: The influence of N-Terminal Hydrophobic Regions
175. Scorpion Toxins that Cause Human Intoxication
176. Is the Endogenous Opioid System Involved in the Antalgic Effect of Scorpion Toxins in Mice?
177. IgY Antibodies Anti- Tityus caripitensis Venom: Purification and Neutralization Efficacy
178. Development of Nanobodies and Derivatives with High Neutralizing and Protective Capacity against Scorpion Envenoming
179. Automated Mass Fingerprinting of Scorpion Venoms in the Nanogram Range
180. Increased Incidence of Tityus trivittatus Envenoming in the City of Buenos Aires
181. Evaluation of a Four-Hour Endpoint for Use in Scorpion Envenomation Studies in Morocco
182. Two Case Studies of Pregnancy Outcomes after Scorpion Envenomation and F(ab')2 Scorpion Antivenom Treatment
183. Development of Immune Sera Against Algerian Scorpion Venoms: Which Antibodies for Envenoming Treatment in Regions At-Risk?
184. Development of Novel Scorpion Anti-Venoms in México
185. Safety of Equine F(ab’)2 Antivenom for Scorpion Envenomation: Results of Prospective Clinical Trials
186. Effects of Captivity or Season on Venom Composition in Two Species of Rattlesnakes ( Crotalus atrox and C. v. viridis )
187. Metalloproteinases from Rear-Fanged (“Colubrid”) Snake Venoms: An Under-Utilized Resource for Evolutionary and Structure/Function Studies
188. The In vitro Neurotoxic Effects of the Newly Discovered Central Ranges Taipan ( Oxyuranus temporalis )
189. Neutralization Effect of Glycation on Myotoxic and Nephrotoxic Effects Induced by BthTX-I
190. First Draft of the Genomic Organization of a PIII-SVMP Gene
191. Dexamethasone Antagonizes the Myotoxic and Inflammatory Effect of Bothrops Venoms
192. Action of Venom Metalloproteinases on Basement Membranes: Pathogenesis of Hemorrhage and Blistering in Snakebite Envenomings
193. A Study of Venoms from Individual Snakes of Two Populations of Rhinocerophis (Bothrops) alternatus of Argentina
194. Effect of Heparin and L-Arginine on Skin Tissue Regeneration after Cerastes cerastes Envenomation
195. A Novel Vascular Endothelial Growth Factor-Like Protein from Gloydius tsushimaensis Venom
196. Synthetic Peptides from Viperid Phospholipase A2 Myotoxins: Small Structures with Diverse Biomimetic Actions
197. Lupane Triterpenoids from Dipteryx alata Vogel as Snake Venom Inhibitors
198. Isolation, Enzymatic Characterization and Action as Spreading Factor of a Hyaluronidase from Crotalus durissus terrificus Snake Venom
199. BaPLA2-IV, an Acidic Phospholipase A2, Isolated From Bothrops atrox Snake Venom: Biochemical and Functional Characterization
200. Antinociceptive Potential of Raw Venom of Egyptian Cobra and Black Tiger Snake: A Functional Magnetic Resonance Imaging Study
201. Molecular Evolution of Snake Venom Phospholipase A2 (PLA2) Genes -Analysis of Group I PLA2 cDNAs from Venomus and Nonvenomous Snakes, and Lizards
202. Brazilian Coral Snake Phospholipases A2 Induce Neuronal Death in Primary Cultures of Hippocampal Neurons
203. Cellular and Humoral Immune Responses in Horses Immunized with Crotalus Venom
204. Vipera Lebetina Venom Nucleases and Nucleotidases
205. A Novel Fluorometric Assay for the Evaluation of Substrates for Phospholipase A2 from the Colombian Snakes Bothrops asper and Crotalus durissus cumanensis
206. Isolation and Characterization of a D49 Phospholipase A2 from Rhinocerophis (Bothrops ) Ammodytoides venom
207. Developing of an Antielapidic Sera by Genetic immunization
208. Fucose Moieties Are Essential for the Ability of Fucosylated Chondroitin Sulfate to Inhibit Muscle Damage Induced by Bothrops jararacussu Venom
209. Venom-Antivenin Binding and Neutralization of Venom Toxicity: Application of Size-Exclusion Chromatography to Assess Venom-Antivenin Binding
210. Understanding the Preclinical Efficacy Profile of Antivenoms: From the Lethality Potency Assay to Antivenomics
211. Effect of Low Level Laser Therapy (LLLT) on Bothrops jararacussu Venom-Induced Myotoxicity in Muscle Cells
212. Effect of Light Emitting Diode (LED) in the Inflammatory Response and Myonecrotic Effect Induced by Bothrops asper Snake Venom
213. Evaluation of Cabenegrin on the Enzymatic Activity and Structure of Basic sPLA2 of Crotalus durissus terrificus Venom
214. Evaluation of the Antiophidic Activity of Lapachol and Synthetic Analogues
215. Ability of Polyanions to Antagonize the Cardiotoxic Effect of the Bothrops jararacussu Venom
216. Experimental, Immunochemical Reactivity and Neutralizing Capacity of Rhinocerophis (Bothrops) alternatus Antivenoms, from Distinct Geographical Sources
217. IgY Antibodies Anti- Crotalus durissus cumanensis Venom: Purification and Neutralization Efficacy
218. Purification of a Metalloprotease from Naja nigricollis Venom and Production of Polyclonal Antibodies
219. Functional Characterization of a Recombinant Myotoxin Inhibitor from Bothrops alternatus Snake Plasma
220. Evaluation of Extracts and Partitions from Aerial Parts of Baccharis microdonta on Enzymatic Activity, Pro-Inflammatory and Myotoxic Activities Induced by Secretory Phospholipase A2 from Bothrops jararacussu
221. The Interaction of the Antitoxin DM43 with a Snake Venom Metalloproteinase Analyzed by Mass Spectrometry and Surface Plasmon Resonance
222. Molecular Mechanisms Involved in PGE2 Release Induced by the Snake Venom Metalloproteinase BaP1 in Synoviocytes
223. TLR2 and MyD88 Signaling are Required for Efficient Response of Macrophages to MT-III a Phospholipase A2 (PLA2) from Bothrops asper Snake Venom
224. Snake Venomics of Crotalus tigris . Evolutionary Clues for Generating a Pan-Specific Antivenom Against Crotalid Type II Venoms
225. Proteomic Analysis and Pharmacological Activities of the Venom of the Moroccan Cobra Naja haje legionis.
226. Processing of SVMPs: Detection of SVMP Zymogens and Pro-Domain in Bothrops jararaca Venom and Venom Glands
227. Proteopeptidome Determination of Bothrops jararaca Venom: an Innovative Approach in Snake Venomics
228. Venom Variability and Envenoming Severity Outcomes of the Crotalus scutulatus scutulatus (Mojave Rattlesnake) from Southern Arizona
229. Geographic Variation of Venom Proteins and Neurotoxicity in the Southern Pacific Rattlesnake ( Crotalus oreganus helleri )
230. Determining the Interaction Region Between the Antimyotoxin DM64 and a Snake Venom Myotoxin
231. Second Generation Antivenomics: Comparing Immunoaffinity and Immunodepletion Protocols
232. Death Adder Envenoming Causes Neurotoxicity not Reversed by Antivenom - Australian Snakebite Project (ASP-16)
233. Hospital Based Retrospective Study of Snakebite Epidemiology in Western Development Region of Nepal
234. Severity of Snakebites in Children in the United States: 2000-2009
235. Antivenom Therapy Following Snakebite: Effectiveness and Strategies for Delivery in West Africa
236. Determinants of High Cost of Care Among Victims of Snake Bite in Kaltungo, Gombe State, Nigeria, 2009
237. Snakebite Survivors Club: Ten-year, retrospective review of Crotaline envenomations in Central California
238. Incidence and Management of Snakebite in Northern Central African Republic
239. Combined Neurotoxicity and Hematotoxicity with Clinically Significant Bleeding after Mohave Rattlesnake ( Crotalus scutulatus ) Envenoming in Southern California
240. Development of a Double Sandwich Flourescent ELISA to Detect Rattlesnake Venom In Biological Samples from Horses with a Clinical Diagnosis of Rattlesnake Bite
241. Juvenile Rattlesnake Fang as a Retained Foreign Body: Clinical Diagnosis
242. The Effect of Pre-hospital Care for Venomous Snakebite on Outcome in Nigeria
243. Continuous Crotalidae Polyvalent Fab (Ovine) (FabAV) for Selected Snakebite Patients
244. Mulga snake ( Pseudechis australis ) Bites; A Review of Significant Cases Including an Exceptionally Severe Local Envenoming
245. Pressure Bandaging with Immobilization in Crotalinae Envenomation Controversy
246. Non-front-fanged Colubroids; A Current Analysis of Medical Significance
247. Envenomation by Daboia mauretanica Snakes in Tiznit Province, Morocco: Report of Four Cases
248. Venomous Mixtures, Gamma Irradiation and Antivipmyn Africa®
249. Experience with Crotalidae Polyvalent Immune Fab (Ovine) for a non-North American Rattlesnake Envenomation
250. Critical Shortage of Coral Snake Antivenom is Impacting Patient Care
251. Acute Hypersensitivity Reaction Following Administration of Crotalidae Polyvalent Immune Fab Antivenom: A Case Report
252. Coral Snake Antivenin's Deadly Deadline
253. Medically Significant Late Bleeding Following Treated Crotaline Envenomation: A Structured Topic Review
254. Failure to Develop Sensitization Despite Repeated Administration of Ovine Fab Snake Antivenom: A Single-Patient, Multi-Center Case Series
255. Local Damage produced by Vipera and Macrovipera Venoms and Some Immunochemical Characteristics
256. A Rapid Reconstitution Method for CroFab® Polyvalent Immune Fab (ovine)
257. Comparative Analysis of Transcriptomes of Phoneutria pertyi and P. nigriventer Venom Glands
258. Unusual Cases of the Spider Cheiracanthium Punctorium Biting in Volgograd Region, Russia
259. Molecular Basis for the Interaction of Tarantula Toxin Jingzhaotoxin-III (β-TRTX-Cj1α) with the Voltage Sensor of Kv2.1 Channel
260. Hainantoxin-III Inhibits Voltage-Gated Sodium Channel Nav 1.7 and Extenuates Inflammatory Pain in Animal Models
261. Expanding Structural and Functional Diversity of Spider Venom Compounds
262. Spider Venom Components Affecting the Function of Purinergic Receptors
263. Molecular Cloning and Characterization of a Sphingomyelinase D from Loxosceles adelaida , a Brazilian Brown Spider from Karstic Areas
264. Milking and Partial Characterization of Pamphobeteus spp (Aranae; Theraphosidae) Venom, from the Colombian Andean Region
265. Poke but Don't Pinch: Risk Assessment and Defensive Behaviors of the Western Widow Spider ( Latrodectus hesperus )
266. C5a Receptor is Cleaved by Metalloproteases Induced by Sphingomyleinase D in Loxosceles Spider Venom
267. A Survey of Venom from the Spitting Spider Scytodes includes Novel Toxins
268. Biological activities of PnTx2-6, an exciting toxin from spider Phoneutria nigriventer
269. Understanding the Chemical Diversity and Evolution of Spider Venoms using Comparative Transcriptomics
270. Site-Directed Mutagenesis of rPnTx2-6 - A Recombinant Phoneutria nigriventer Spider Venom Toxin – Reveals Important Amino Acids for Its Pharmacological Activities
271. Differential Expression of Aquaporin 4 in the Hippocampus of Neonate and Adult Rats after Envenoming by Phoneutria nigriventer(Ctenidae, Araneomorphae)
272. Cellular and Molecular Demonstration that Vascular Endothelial Growth Factor (VEGF) and its Receptor Flt-1 and Flk-1 are Involved in Phoneutria nigriventer Envenoming
273. Heterologous Expression of PaluIT1, A Cysteine Knot Spider Toxin, in E. coli .
274. A National Serum Depot in the Netherlands; Encountered Antivenom Purchase Difficulties
275. Safe Utilization of Ketamine as a First Line Induction Agent for Rapid Sequence Intubation (RSI) in the Aeromedical Setting
276. Circus Venomous: An Interactive Tool for Toxinology Education
277. Prehospital Management of Envenomations in the State of Queensland, Australia
278. Epidemiologic Situation of Envenomation by Venomous Animals in Argentina. 2007-2011 Period
279. Travel Toxinology: An Illustrative Case of Brown Spotted Pit Viper ( Protobothrops mucrosquamatus ) Bite With Review of Clinical Toxinology Issues in Travel Medicine
280. Genetic Regulation of Venom Production during Embryonic Development of the Indochinese Spitting Cobra, Naja siamensis
281. The Desert Massasauga ( Sistrurus catenatus edwardsii ): Biology and Venom Biochemistry
282. Sexual Variation in Timing of Egress and Ingress in Tiger Rattlesnakes ( Crotalus tigris )
283. Relocator Proteins: Identification of the Chemical Component of Venoms Allowing Prey Recovery During Strike-induced Chemosensory Searching
284. The Bio-Logic of Venom Complexity
285. Venomous Workshop: Evolution of a Professional Training Course
286. Legal Conundrums Impeding Patient Safety Initiative to Prevent Exotic Envenomation in the United States
287. Logistics and Problems in Managing a Large Confiscation of Venomous Snakes
288. Unique Challenges Faced During the Creation of a New Herpetology Department with New Venomous Animal Species and Safety Policies within the City of Virginia Beach's Virginia Aquarium and Marine Science Center
289. 2011 Putnam County Venomous Snake Confiscation: Antivenom Coverage Decisions
290. Microbiological Evaluation of Different Strategies for Management of Snakes in Captivity
291. The Dilemma: Balancing Antivenom Cost vs. Investment in Conservation
292. How Do Komodo Dragons Kill Their Prey?: Lack of Role for Oral Flora in Predation
293. Coral Snakes, Antivenoms, Hospitals and Zoos: How Can One Little Snake Cause So Many Problems?
294. A Randomized Multicenter Trial of Crotalidae Polyvalent Immune Fab Antivenom for the Treatment of Rattlesnake Envenomation in Dogs
295. F(ab’)2 Antivenom in Dogs Envenomated by Pit Vipers
296. Crotalidae Venom Levels in Dogs Before and After Administration of F(ab’)2 Antivenom
297. A Retrospective Review of Coral Snake Envenomation in the Dog and Cat: 20 cases 1996 to 2011